Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.20 $16.47 Friday, 10th May 2024 VRDN stock ended at $13.90. This is 0.0719% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.32% from a day low at $13.34 to a day high of $14.05.
90 days $12.20 $21.42
52 weeks $10.93 $28.35

Historical Viridian Therapeutics, Inc. prices

Date Open High Low Close Volume
Oct 05, 2023 $14.12 $14.71 $13.80 $14.54 431 104
Oct 04, 2023 $14.04 $14.32 $13.56 $14.16 947 525
Oct 03, 2023 $14.51 $14.54 $13.75 $14.09 880 653
Oct 02, 2023 $15.35 $15.35 $14.40 $14.60 645 280
Sep 29, 2023 $15.31 $15.38 $14.66 $15.34 479 809
Sep 28, 2023 $15.37 $15.55 $14.87 $15.16 417 001
Sep 27, 2023 $15.55 $15.69 $15.19 $15.37 339 514
Sep 26, 2023 $15.52 $15.86 $15.20 $15.53 464 821
Sep 25, 2023 $15.67 $15.94 $15.30 $15.44 448 055
Sep 22, 2023 $15.76 $15.80 $15.35 $15.54 367 924
Sep 21, 2023 $16.22 $16.22 $15.63 $15.74 617 611
Sep 20, 2023 $17.11 $17.11 $16.31 $16.37 389 245
Sep 19, 2023 $17.40 $17.49 $16.88 $17.05 288 762
Sep 18, 2023 $17.45 $17.50 $17.05 $17.28 424 365
Sep 15, 2023 $17.50 $17.70 $17.23 $17.53 1 057 673
Sep 14, 2023 $16.88 $17.60 $16.88 $17.52 583 522
Sep 13, 2023 $17.60 $17.73 $16.40 $16.75 1 350 150
Sep 12, 2023 $17.85 $18.56 $17.65 $17.75 750 915
Sep 11, 2023 $18.18 $18.49 $17.78 $17.87 739 634
Sep 08, 2023 $18.80 $18.80 $18.10 $18.18 887 817
Sep 07, 2023 $18.75 $19.00 $18.18 $18.73 403 406
Sep 06, 2023 $19.38 $19.72 $18.86 $18.95 702 617
Sep 05, 2023 $19.08 $19.37 $18.78 $19.35 542 297
Sep 01, 2023 $18.28 $19.12 $18.28 $19.11 594 453
Aug 31, 2023 $18.40 $18.63 $18.13 $18.17 383 862
Click to get the best stock tips daily for free!

About Viridian Therapeutics, Inc.

Viridian Therapeutics. Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as ... VRDN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT